Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Skimmianine Pretreatment Attenuates Cerebellar Neuroinflammation and Myelin Injury Following Experimental Cerebral Ischemia-Reperfusion.
Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies-3rd Edition.
Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine.
Anti-NMDA-receptor encephalitis and MOGAD associated optic neuritis: a case series.
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosis.
Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis.
Comment on "Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission".
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles.
Eculizumab treatment in the salvage therapy of MOGAD: a case report.
Ventricular-vascular coupling at rest and immediately following maximal exercise in adults with and without multiple sclerosis.
Sequence Variation of Epstein-Barr Virus EBNA-1 Gene in Central Nervous System Inflammatory Demyelinating Diseases in Pakistan.
Investigating functional brain networks in multiple sclerosis patients: a graph theory approach for evaluating working memory impairment.
Running Participation in People With Multiple Sclerosis: A Prospective Observational Cohort Study.
Interthalamic adhesion alterations in multiple sclerosis: associations with thalamic damage and cognition.
Antigliotic guiding regenerative gel: a bioactive hydrogel platform for peripheral nerve and spinal cord repair.
Epstein-Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity.
Neuropharmacology of Cannabinoids: A Comprehensive Review of Preclinical and Clinical Evidence for Hemp-Derived Extracts and Active Compounds.
Functional Connectivity at Rest and During Cognitive Processing in Multiple Sclerosis: A Pilot Magnetoencephalography Study and Systematic Review.
Contrast-Enhanced Ultrasound Demonstrates a Severity-Dependent Hemodynamic Response to Acute Dural Decompression in Contusive Rodent Spinal Cord Injury.
Walking performance is associated with quality of life and disability in relapsing-remitting multiple sclerosis.
α2-3-sialylated glycosphingolipids in neuroinflammation, immunity, and programmed cell death: mechanistic evidence and context-dependent regulation: a comprehensive review.
Motor System Neurodegeneration in Aging and Synucleinopathies: Circuit Vulnerability and Neuroimaging Biomarkers.
Brainstem and callosal T2-hyperintense lesions with normal MRS: an EBV-driven T-cell mimic of demyelination.
Life-threatening multisystem sarcoidosis with neurological, renal, ocular and autoimmune haemolytic manifestations treated with intravenous immunoglobulin, plasma exchange, cyclophosphamide and infliximab.
Pages
« first
‹ previous
…
945
946
947
948
949
950
951
952
953
…
next ›
last »